Search for other papers by Sonja Kunz in
Google Scholar
PubMed
Search for other papers by Xiao Wang in
Google Scholar
PubMed
Search for other papers by Uta Ferrari in
Google Scholar
PubMed
Search for other papers by Michael Drey in
Google Scholar
PubMed
Search for other papers by Marily Theodoropoulou in
Google Scholar
PubMed
Search for other papers by Katharina Schilbach in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
KORA Study Centre, University Hospital of Augsburg, Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
German Heart Centre Munich, Technical University of Munich, Munich, Germany
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
German Centre for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg, Germany
Search for other papers by Tanja Zeller in
Google Scholar
PubMed
Search for other papers by Barbara Thorand in
Google Scholar
PubMed
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
this method, we analyzed samples from the population-based Cooperative Health Research in the Region of Augsburg (KORA) studies; generated method-specific RIs; and investigated the impact of sex, age, and BMI. Materials and methods Subjects
Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Search for other papers by Pascal Probst in
Google Scholar
PubMed
Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Search for other papers by Markus K Muller in
Google Scholar
PubMed
Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Search for other papers by Achim Weber in
Google Scholar
PubMed
Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
spreadsheet (Microsoft Excel ® ). Categorical data were presented as frequencies and percentages. Age was presented as median with range and mean ± s.d. Age was compared between asymptomatic carriers and symptomatic patients, female and male patients at
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
features, including sex, age, grade, and the primary tumor site may also significantly influence the prognosis ( 12 ). To the best of our knowledge, only a few studies have used nomograms to predict the prognosis of all patients with NETs ( 13 , 14 , 15
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Shanshan Yu in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Chun Liu in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
analysed 52 patients with PTL and 40 patients with DSVPTC were confirmed by surgical pathology. Representative histological figures of PTL and DSVPTC were shown in Fig. 1 . The median age at presentation of patients with PTL was 64.5 years, while DSVPTC
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Nikolaos Kyriakakis in
Google Scholar
PubMed
Search for other papers by Marilena Giannoudi in
Google Scholar
PubMed
Search for other papers by Satish S Kumar in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Khyatisha Seejore in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Harpal Randeva in
Google Scholar
PubMed
Leeds Institute of Medical Research, University of Leeds, UK
Search for other papers by Adam Glaser in
Google Scholar
PubMed
Search for other papers by Michelle Kwok-Williams in
Google Scholar
PubMed
Search for other papers by Georgina Gerrard in
Google Scholar
PubMed
Search for other papers by Carmel Loughrey in
Google Scholar
PubMed
Search for other papers by Ahmed Al-Qaissi in
Google Scholar
PubMed
Search for other papers by Ramzi Ajjan in
Google Scholar
PubMed
Search for other papers by Julie Lynch in
Google Scholar
PubMed
Leeds Institute for Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds, Leeds, UK
Search for other papers by Robert D Murray in
Google Scholar
PubMed
malignant brain tumours before the age of 15 years ( 1 ). Not dissimilar outcomes are observed in teenage and young adults (15–40 years), in whom 5-year survival approaches 68%. In contrast, considerably lower 5-year survival rates of up to 20% are observed
Department of Public Health, Erasmus University Medical Center, Rotterdam, Netherlands
Search for other papers by Josephina G Kuiper in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Aline C Fenneman in
Google Scholar
PubMed
Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Elena Rampanelli in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Max Nieuwdorp in
Google Scholar
PubMed
Search for other papers by Myrthe P P van Herk-Sukel in
Google Scholar
PubMed
Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands
Search for other papers by Valery E P P Lemmens in
Google Scholar
PubMed
Search for other papers by Ernst J Kuipers in
Google Scholar
PubMed
Department of Epidemiology and Data Science, Amsterdam UMC, Amsterdam, Netherlands
Search for other papers by Ron M C Herings in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
and 2014 with primary CRC (ICD 10-CM code C18-C20) were identified. The first date of CRC diagnosis was defined as the index date. To reduce the likelihood of including patients with heritable CRC syndromes, patients younger than 40 years of age at
Search for other papers by J Gebauer in
Google Scholar
PubMed
Search for other papers by R Skinner in
Google Scholar
PubMed
Search for other papers by R Haupt in
Google Scholar
PubMed
Amsterdam UMC, Emma’s Children’s Hospital, Amsterdam, The Netherlands
Search for other papers by L Kremer in
Google Scholar
PubMed
Search for other papers by H van der Pal in
Google Scholar
PubMed
Search for other papers by G Michel in
Google Scholar
PubMed
Search for other papers by G T Armstrong in
Google Scholar
PubMed
Search for other papers by M M Hudson in
Google Scholar
PubMed
Search for other papers by L Hjorth in
Google Scholar
PubMed
Search for other papers by H Lehnert in
Google Scholar
PubMed
Search for other papers by T Langer in
Google Scholar
PubMed
. Figure 1 Changes in 5-year relative survival (in %, y-axis) for childhood cancer patients (age: 0–14 years) with different cancer entities (x-axis) between 1975 and 2012 (data from ( 1 )). Despite the advances in cancer treatment, many long
Search for other papers by Enrique Pedernera in
Google Scholar
PubMed
Search for other papers by Flavia Morales-Vásquez in
Google Scholar
PubMed
Search for other papers by María J Gómora in
Google Scholar
PubMed
Search for other papers by Miguel A Almaraz in
Google Scholar
PubMed
Universidad La Salle, Posgrado de la Facultad de Ciencias Químicas, Ciudad de México, México
Search for other papers by Esteban Mena in
Google Scholar
PubMed
Search for other papers by Delia Pérez-Montiel in
Google Scholar
PubMed
Search for other papers by Elizabeth Rendon in
Google Scholar
PubMed
Search for other papers by Horacio López-Basave in
Google Scholar
PubMed
Search for other papers by Juan Maldonado-Cubas in
Google Scholar
PubMed
Search for other papers by Carmen Méndez in
Google Scholar
PubMed
characteristics of the patients who were included in the study and the percentage of patients with tumors positive and negative for 17β-HSD1 expression. The median age of the patient was 48 years, with a similar age concerning HSD17β1 expression. Borderline tumors
Search for other papers by Orwa Dandash in
Google Scholar
PubMed
Search for other papers by James Allebone in
Google Scholar
PubMed
Search for other papers by Adam Mirabelli in
Google Scholar
PubMed
Search for other papers by Nicholas Russell in
Google Scholar
PubMed
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia
Search for other papers by Andrea Gogos in
Google Scholar
PubMed
Search for other papers by Richard A Kanaan in
Google Scholar
PubMed
condition) as well as the interaction between them. Age was entered as a variable of no interest. Confirmatory t- tests followed to examine differences in activation over time. To this end, the t -test results were masked by the interaction results to
Search for other papers by Arnaud Lagarde in
Google Scholar
PubMed
Search for other papers by Grégory Mougel in
Google Scholar
PubMed
Search for other papers by Lucie Coppin in
Google Scholar
PubMed
Search for other papers by Magalie Haissaguerre in
Google Scholar
PubMed
Inserm/CNRS UMR 1283/8199, Pasteur Institute of Lille, EGID, Lille, France
Search for other papers by Lauriane Le Collen in
Google Scholar
PubMed
Search for other papers by Amira Mohamed in
Google Scholar
PubMed
Search for other papers by Marc Klein in
Google Scholar
PubMed
Univ. Lille, Inserm, CHU Lille, U1286 – Infinite – Institute for Translational Research in Inflammation, Lille, France
Search for other papers by Marie-Françoise Odou in
Google Scholar
PubMed
Search for other papers by Antoine Tabarin in
Google Scholar
PubMed
Search for other papers by Hedia Brixi in
Google Scholar
PubMed
Search for other papers by Thomas Cuny in
Google Scholar
PubMed
Search for other papers by Brigitte Delemer in
Google Scholar
PubMed
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by Pauline Romanet in
Google Scholar
PubMed
for the rest of the 62 kb panel). Cohort of unresolved MEN1 cases One hundred nineteen patients (40 males and 79 females) were included in the study. Their average age at the time of genetic testing was 54 years (range 17–86 years). Patients